At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
#HerHeart toolbehavioral
Likely dose
Not stated in record
Key inclusion· 6
- ✓Age 13-21 years
- ✓Self-identifying as female
- ✓Self-identifying as non-Hispanic Black or White race (inclusive of Hispanic ethnicity)
- ✓Patient at CHOA Hughes Spalding Adolescent Medicine Practice or the Grady Health System Teen Program
Key exclusion· 6
- ✕Diagnosis of hypertension, diabetes, or hyperlipidemia requiring medications, or atherosclerotic cardiovascular disease
- ✕Past or current diagnosis of a DSM-V eating disorder
- ✕Diagnosis of schizophrenia, bipolar disorder, or psychiatric hospitalization in the past 12 months
- ✕Cognitive impairment limiting ability to complete study procedure
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Incorporating Cardiovascular Risk Assessment Into Adolescent and Young Adult Visits to Improve Cardiovascular Health
In Brief
A clinical study evaluating #HerHeart tool for Cardiovascular Diseases. Completed, enrolled 60 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the web tool #HerHeart's usability and feasibility in adolescent and young adult women (AYA) and the opinion of their healthcare providers (HCP).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2023202420252026
First PostedMay 2022
Enrollment StartJul 2022
Primary CompletionApr 2023
TodayJul 2026
First PostedMay 20, 2022
Enrollment StartJul 1, 2022
Primary CompletionApr 3, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.1 years ago
Interventions
#HerHeart toolbehavioral
An integrated application consisting of a lifestyle-based CVD risk assessment and companion behavioral intervention. It will be administered at baseline and 3 months follow-up.